MODULATORS OF 5-HT RECEPTORS Russian patent published in 2008 - IPC C07D223/14 C07D223/16 C07D487/00 C07D491/00 C07D513/00 A61K31/55 A61P3/04 A61P25/24 

Abstract RU 2317982 C2

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to novel compounds of the formula (I): wherein R1 means hydrogen atom (H) or (C1-C8)-alkyl; R2 means (C1-C8)-alkyl, -CH2-O-(C1-C8)-alkyl, -OH or -CH2OH; R2a means H; or R2 and R2a for in common -CH2-CH2-; R3 means halogen atom, perhalogenalkyl, -CN, -SR5, -NHR5, -N(R5)2, aryl or heteroaryl wherein indicated aryl can comprise optionally up to two substitutes chosen from (C1-C8)-alkyl, halogen atom, perhalogenalkyl and alkoxy-group, and indicated heteroaryl can comprise optionally up to two substitutes chosen from halogen atom and (C1-C8)-alkyl; R4 means H, halogen atom, perhalogenalkyl, -CN, -OR5, -SR5, -NHR5, -N(R5)2, -OH, aryl or heteroaryl wherein indicated aryl can comprise optionally up to two substitutes chosen from (C1-C8)-alkyl, halogen atom, perhalogenalkyl and alkoxy-group, and indicated heteroaryl can comprise optionally up to two substitutes chosen from halogen atom and (C1-C8)-alkyl; or R3 and R in common with atoms to which they are added can form 5- or 6-membered heterocyclic ring comprising one oxygen atom (O); each R5 means independently (C1-C8)-alkyl, (C2-C8)-alkenyl, aryl, heteroaryl, arylalkyl, alheteroarylalkyl, perhalogenalkyl or allyl; R6 means H or (C1-C8)-alkyl, or their pharmaceutically acceptable salts, solvates or hydrates under condition that if R6 differs from H then R4 can't mean H; if R1 and R2 mean methyl and R4 means H then R3 can't -NHR5 or -N(R5)2; if R1 and R2 mean methyl and R4 means H then R3 can't imidazole, substituted imidazole or imidazole derivative. Also, invention relates to a pharmaceutical composition used for modulation of 5-HT2C receptors, a method for modulation of 5-HT2C receptors, a method for prophylaxis or treatment of disorders of the central nervous system and obesity, a method for reducing food consumption in mammals, a method for inducing the satisfying sense in mammals and to a method for preparing the composition. Invention provides synthesis of novel compounds possessing useful biological properties and preparing pharmaceutical composition based on thereof.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

70 cl, 1 tbl, 57 ex

Similar patents RU2317982C2

Title Year Author Number
CONDENSED AZEPINE DERIVATIVES AS ANTIDIUTETIC AGENTS 2001
  • Ehshuehrt Dorin Mehri
  • Pitt Gari Robert Uil'Jam
  • Khadson Piter
  • Jej Kristofer Martin
  • Franklin Richard Dzheremi
  • Sempl Grem
  • Dzhenkins Dehvid Pol
RU2269517C2
BICYCLIC AGONISTS OF VASOPRESSIN 2000
  • Ashuehrt Dorin Mehri
  • Pitt Gari Robert Uil'Jam
  • Khadson Piter
  • Jej Kristofer Martin
  • Franklin Richard Dzheremi
RU2254332C2
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD 2003
  • Bamford Mark Dzhejms
  • Din Dehvid Kennet
  • Sekhmi Sandzhit Singkh
  • Uilson Dehvid Mehtt'Ju
  • Vizerington Dzhejson
RU2388752C2
CETP INHIBITORS 2006
  • Ali Amdzhad
  • Lu Chzhitszjan'
  • Sinkler Piter Dzh
  • Chehn' I-Khehn
  • Smit Kameron Dzh
  • Li Khun
RU2513107C2
NEW BENZAZEPIN DERIVATIVES 2003
  • Bamford Mark Dzhejms
  • Din Dehvid Kennet
  • Sekhmi Sandzhit Singkh
  • Uilson Dehvid Mehtt'Ju
  • Vizerington Dzhejson
RU2423353C1
COMPOUNDS 2003
  • Gribbl Ehndrju Derrik
  • Forbs Jan Tomson
  • Lajtfut Ehndrju
  • Pejn Ehndrju Kh.
  • Uolker Grehkham
  • Gartsija Vinchentso
RU2327690C2
HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND THEIR USING 2001
  • Bridzher Gari
  • Skerldzh Renato
  • Kehller Ehl
  • Kharvig Kertis
  • Bogutskij Dehvid
  • Uilson Trevor R.
  • Kroford Dzhejson
  • Makichern Ehrnest Dzh.
  • Atsma Bem
  • Nan Sikvajao
  • Zou Juanksi
  • Skhols Dominik
  • Smit Kristofer Dennis
  • Di Fluri Rozaria Marija
RU2289581C2
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD 2000
  • Bek Dzhejms P.
  • Smit Mark A.
RU2293728C2
6-5 CONDENSED RINGS AS C5a INHIBITORS 2018
  • Fan, Pingchen
  • Lange, Christopher W.
  • Lui, Rebecca M.
  • Malathong, Viengkham
  • Mali, Venkat Reddy
  • Punna, Sreenivas
  • Singh, Rajinder
  • Tanaka, Hiroko
  • Zeng, Yibin
  • Zhang, Penglie
RU2780338C2
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS 2005
  • Adida Rua Sara S.
  • Khejzlvud Anna R.
  • Grotenkhejs Peter D.,J.
  • Van Gur Frederik F.
  • Singkh Ashvani K.
  • Chzhou Tszinlan'
  • Makkartni Dzhejson
RU2528046C2

RU 2 317 982 C2

Authors

Smit Brajan

Smit Dzhefri

Dates

2008-02-27Published

2003-04-11Filed